Submitted by Anonymous (not verified) on 12 October 2023 - 10:29
Human medicines European public assessment report (EPAR): Cometriq, cabozantinib, Thyroid Neoplasms, Date of authorisation: 21/03/2014, Revision: 28, Status: Authorised
Source: